A company spokesperson said Dexcom ... its popular G6 & G7 sensor manufacturing. The company response is inadequate. DexCom (NasdaqGS:DXCM) witnessed a 4% increase in its share price over the ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to investors on Monday, March 10th. William Blair analyst M. Andrew now forecasts that ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...